Cargando…
The PDGFRα-laminin B1-keratin 19 cascade drives tumor progression at the invasive front of human hepatocellular carcinoma
Human hepatocellular carcinomas (HCCs) expressing the biliary/hepatic progenitor cell marker keratin 19 (K19) have been linked with a poor prognosis and exhibit an increase in platelet-derived growth factor receptor α (PDGFRα) and laminin beta 1 (LAMB1) expression. PDGFRα has been reported to induce...
Autores principales: | , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5702717/ https://www.ncbi.nlm.nih.gov/pubmed/28783171 http://dx.doi.org/10.1038/onc.2017.260 |
_version_ | 1783281575354433536 |
---|---|
author | Govaere, O Petz, M Wouters, J Vandewynckel, Y-P Scott, E J Topal, B Nevens, F Verslype, C Anstee, Q M Van Vlierberghe, H Mikulits, W Roskams, T |
author_facet | Govaere, O Petz, M Wouters, J Vandewynckel, Y-P Scott, E J Topal, B Nevens, F Verslype, C Anstee, Q M Van Vlierberghe, H Mikulits, W Roskams, T |
author_sort | Govaere, O |
collection | PubMed |
description | Human hepatocellular carcinomas (HCCs) expressing the biliary/hepatic progenitor cell marker keratin 19 (K19) have been linked with a poor prognosis and exhibit an increase in platelet-derived growth factor receptor α (PDGFRα) and laminin beta 1 (LAMB1) expression. PDGFRα has been reported to induce de novo synthesis of LAMB1 protein in a Sjogren syndrome antigen B (La/SSB)-dependent manner in a murine metastasis model. However, the role of this cascade in human HCC remains unclear. This study focused on the functional role of the PDGFRα-La/SSB-LAMB1 pathway and its molecular link to K19 expression in human HCC. In surgical HCC specimens from a cohort of 136 patients, PDGFRα expression correlated with K19 expression, microvascular invasion and metastatic spread. In addition, PDGFRα expression in pre-operative needle biopsy specimens predicted poor overall survival during a 5-year follow-up period. Consecutive histological staining demonstrated that the signaling components of the PDGFRα-La/SSB-LAMB1 pathway were strongly expressed at the invasive front. K19-positive HCC cells displayed high levels of α2β1 integrin (ITG) receptor, both in vitro and in vivo. In vitro activation of PDGFRα signaling triggered the translocation of nuclear La/SSB into the cytoplasm, enhanced the protein synthesis of LAMB1 by activating its internal ribosome entry site, which in turn led to increased secretion of laminin-111. This effect was abrogated by the PDGFRα-specific inhibitor crenolanib. Importantly LAMB1 stimulated ITG-dependent focal adhesion kinase/Src proto-oncogene non-receptor tyrosine kinase signaling. It also promoted the ITG-specific downstream target Rho-associated coiled-coil containing protein kinase 2, induced K19 expression in an autocrine manner, invadopodia formation and cell invasion. Finally, we showed that the knockdown of LAMB1 or K19 in subcutaneous xenograft mouse models resulted in significant loss of cells invading the surrounding stromal tissue and reduced HepG2 colonization into lung and liver after tail vein injection. The PDGFRα-LAMB1 pathway supports tumor progression at the invasive front of human HCC through K19 expression. |
format | Online Article Text |
id | pubmed-5702717 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2017 |
publisher | Nature Publishing Group |
record_format | MEDLINE/PubMed |
spelling | pubmed-57027172017-11-29 The PDGFRα-laminin B1-keratin 19 cascade drives tumor progression at the invasive front of human hepatocellular carcinoma Govaere, O Petz, M Wouters, J Vandewynckel, Y-P Scott, E J Topal, B Nevens, F Verslype, C Anstee, Q M Van Vlierberghe, H Mikulits, W Roskams, T Oncogene Original Article Human hepatocellular carcinomas (HCCs) expressing the biliary/hepatic progenitor cell marker keratin 19 (K19) have been linked with a poor prognosis and exhibit an increase in platelet-derived growth factor receptor α (PDGFRα) and laminin beta 1 (LAMB1) expression. PDGFRα has been reported to induce de novo synthesis of LAMB1 protein in a Sjogren syndrome antigen B (La/SSB)-dependent manner in a murine metastasis model. However, the role of this cascade in human HCC remains unclear. This study focused on the functional role of the PDGFRα-La/SSB-LAMB1 pathway and its molecular link to K19 expression in human HCC. In surgical HCC specimens from a cohort of 136 patients, PDGFRα expression correlated with K19 expression, microvascular invasion and metastatic spread. In addition, PDGFRα expression in pre-operative needle biopsy specimens predicted poor overall survival during a 5-year follow-up period. Consecutive histological staining demonstrated that the signaling components of the PDGFRα-La/SSB-LAMB1 pathway were strongly expressed at the invasive front. K19-positive HCC cells displayed high levels of α2β1 integrin (ITG) receptor, both in vitro and in vivo. In vitro activation of PDGFRα signaling triggered the translocation of nuclear La/SSB into the cytoplasm, enhanced the protein synthesis of LAMB1 by activating its internal ribosome entry site, which in turn led to increased secretion of laminin-111. This effect was abrogated by the PDGFRα-specific inhibitor crenolanib. Importantly LAMB1 stimulated ITG-dependent focal adhesion kinase/Src proto-oncogene non-receptor tyrosine kinase signaling. It also promoted the ITG-specific downstream target Rho-associated coiled-coil containing protein kinase 2, induced K19 expression in an autocrine manner, invadopodia formation and cell invasion. Finally, we showed that the knockdown of LAMB1 or K19 in subcutaneous xenograft mouse models resulted in significant loss of cells invading the surrounding stromal tissue and reduced HepG2 colonization into lung and liver after tail vein injection. The PDGFRα-LAMB1 pathway supports tumor progression at the invasive front of human HCC through K19 expression. Nature Publishing Group 2017-11-23 2017-08-07 /pmc/articles/PMC5702717/ /pubmed/28783171 http://dx.doi.org/10.1038/onc.2017.260 Text en Copyright © 2017 The Author(s) http://creativecommons.org/licenses/by-nc-nd/4.0/ This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivs 4.0 International License. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in the credit line; if the material is not included under the Creative Commons license, users will need to obtain permission from the license holder to reproduce the material. To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/4.0/ |
spellingShingle | Original Article Govaere, O Petz, M Wouters, J Vandewynckel, Y-P Scott, E J Topal, B Nevens, F Verslype, C Anstee, Q M Van Vlierberghe, H Mikulits, W Roskams, T The PDGFRα-laminin B1-keratin 19 cascade drives tumor progression at the invasive front of human hepatocellular carcinoma |
title | The PDGFRα-laminin B1-keratin 19 cascade drives tumor progression at the invasive front of human hepatocellular carcinoma |
title_full | The PDGFRα-laminin B1-keratin 19 cascade drives tumor progression at the invasive front of human hepatocellular carcinoma |
title_fullStr | The PDGFRα-laminin B1-keratin 19 cascade drives tumor progression at the invasive front of human hepatocellular carcinoma |
title_full_unstemmed | The PDGFRα-laminin B1-keratin 19 cascade drives tumor progression at the invasive front of human hepatocellular carcinoma |
title_short | The PDGFRα-laminin B1-keratin 19 cascade drives tumor progression at the invasive front of human hepatocellular carcinoma |
title_sort | pdgfrα-laminin b1-keratin 19 cascade drives tumor progression at the invasive front of human hepatocellular carcinoma |
topic | Original Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5702717/ https://www.ncbi.nlm.nih.gov/pubmed/28783171 http://dx.doi.org/10.1038/onc.2017.260 |
work_keys_str_mv | AT govaereo thepdgfralamininb1keratin19cascadedrivestumorprogressionattheinvasivefrontofhumanhepatocellularcarcinoma AT petzm thepdgfralamininb1keratin19cascadedrivestumorprogressionattheinvasivefrontofhumanhepatocellularcarcinoma AT woutersj thepdgfralamininb1keratin19cascadedrivestumorprogressionattheinvasivefrontofhumanhepatocellularcarcinoma AT vandewynckelyp thepdgfralamininb1keratin19cascadedrivestumorprogressionattheinvasivefrontofhumanhepatocellularcarcinoma AT scottej thepdgfralamininb1keratin19cascadedrivestumorprogressionattheinvasivefrontofhumanhepatocellularcarcinoma AT topalb thepdgfralamininb1keratin19cascadedrivestumorprogressionattheinvasivefrontofhumanhepatocellularcarcinoma AT nevensf thepdgfralamininb1keratin19cascadedrivestumorprogressionattheinvasivefrontofhumanhepatocellularcarcinoma AT verslypec thepdgfralamininb1keratin19cascadedrivestumorprogressionattheinvasivefrontofhumanhepatocellularcarcinoma AT ansteeqm thepdgfralamininb1keratin19cascadedrivestumorprogressionattheinvasivefrontofhumanhepatocellularcarcinoma AT vanvlierbergheh thepdgfralamininb1keratin19cascadedrivestumorprogressionattheinvasivefrontofhumanhepatocellularcarcinoma AT mikulitsw thepdgfralamininb1keratin19cascadedrivestumorprogressionattheinvasivefrontofhumanhepatocellularcarcinoma AT roskamst thepdgfralamininb1keratin19cascadedrivestumorprogressionattheinvasivefrontofhumanhepatocellularcarcinoma AT govaereo pdgfralamininb1keratin19cascadedrivestumorprogressionattheinvasivefrontofhumanhepatocellularcarcinoma AT petzm pdgfralamininb1keratin19cascadedrivestumorprogressionattheinvasivefrontofhumanhepatocellularcarcinoma AT woutersj pdgfralamininb1keratin19cascadedrivestumorprogressionattheinvasivefrontofhumanhepatocellularcarcinoma AT vandewynckelyp pdgfralamininb1keratin19cascadedrivestumorprogressionattheinvasivefrontofhumanhepatocellularcarcinoma AT scottej pdgfralamininb1keratin19cascadedrivestumorprogressionattheinvasivefrontofhumanhepatocellularcarcinoma AT topalb pdgfralamininb1keratin19cascadedrivestumorprogressionattheinvasivefrontofhumanhepatocellularcarcinoma AT nevensf pdgfralamininb1keratin19cascadedrivestumorprogressionattheinvasivefrontofhumanhepatocellularcarcinoma AT verslypec pdgfralamininb1keratin19cascadedrivestumorprogressionattheinvasivefrontofhumanhepatocellularcarcinoma AT ansteeqm pdgfralamininb1keratin19cascadedrivestumorprogressionattheinvasivefrontofhumanhepatocellularcarcinoma AT vanvlierbergheh pdgfralamininb1keratin19cascadedrivestumorprogressionattheinvasivefrontofhumanhepatocellularcarcinoma AT mikulitsw pdgfralamininb1keratin19cascadedrivestumorprogressionattheinvasivefrontofhumanhepatocellularcarcinoma AT roskamst pdgfralamininb1keratin19cascadedrivestumorprogressionattheinvasivefrontofhumanhepatocellularcarcinoma |